Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suresh Kumar Chidambaram

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The Journal of the Royal College of Physicians of Edinburgh|April 20, 2021
Risk factors of carbapenem-resistant Enterobacteriaceae infection and colonisation: a Malaysian tertiary care hospital based case-control studyChuan Huan Chuah, Yasmin Gani, Benedict Sim, et al.
Journal of Clinical Pharmacy and Therapeutics|March 26, 2021
QT prolongation associated with hydroxychloroquine and protease inhibitors in COVID-19Hui Moon Koh, Pei Feng Chong, Ju Nee Tan, et al.
Journal of Infection and Public Health|December 12, 2022
Clinical predictors of efavirenz-based regimen treatment durability: A two-year case-control study of antiretroviral-naïve patientsMathumalar Loganathan Fahrni, Nurul Fatin Laila Misran, Zarena Zainul Abidin, et al.
Saudi Journal of Medicine & Medical Sciences|June 4, 2021
Survival and Prognostic Factors of HIV-positive Patients after Antiretroviral Therapy Initiation at a Malaysian Referral HospitalLee Sing Chet, Siti Azrin Ab Hamid, Norsa'adah Bachok, et al.
BMC Public Health|April 9, 2026
When good knowledge falls short: identity and geography drive inappropriate antibiotic use in MalaysiaZhuo-Lin Chong, Noor Aliza Lodz, Sarbhan Singh, et al.
BMJ Open|January 12, 2026
Defining chronic ambulatory care sensitive conditions in Malaysia: a collaborative consensus studyShakirah Md Sharif, Weng Hong Fun, Suresh Kumar Chidambaram, et al.
The Lancet Regional Health. Western Pacific|February 1, 2021
Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A nationwide observational studyBenedict Lim Heng Sim, Suresh Kumar Chidambaram, Xin Ci Wong, et al.
BMC Infectious Diseases|February 15, 2019
Zika virus infection in Malaysia: an epidemiological, clinical and virological analysisYuan Liang Woon, Mei Fong Lim, Tg Rogayah Tg Abd Rashid, et al.
Nephrology (Carlton, Vic.)|April 19, 2022
COVID-19 death and kidney disease in a multiracial Asian countryBak Leong Goh, Malini Shanmuganathan, Kalaiarasu Peariasamy, et al.
BMC Infectious Diseases|August 5, 2024
Nirmatrelvir/ritonavir treatment and the risk of post-COVID condition over 180 days in MalaysiaEe Vien Low, Mohan Dass Pathmanathan, Yi Yang Ten, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The Journal of the Royal College of Physicians of Edinburgh|April 20, 2021
Risk factors of carbapenem-resistant Enterobacteriaceae infection and colonisation: a Malaysian tertiary care hospital based case-control studyChuan Huan Chuah, Yasmin Gani, Benedict Sim, et al.
Journal of Clinical Pharmacy and Therapeutics|March 26, 2021
QT prolongation associated with hydroxychloroquine and protease inhibitors in COVID-19Hui Moon Koh, Pei Feng Chong, Ju Nee Tan, et al.
Journal of Infection and Public Health|December 12, 2022
Clinical predictors of efavirenz-based regimen treatment durability: A two-year case-control study of antiretroviral-naïve patientsMathumalar Loganathan Fahrni, Nurul Fatin Laila Misran, Zarena Zainul Abidin, et al.
Saudi Journal of Medicine & Medical Sciences|June 4, 2021
Survival and Prognostic Factors of HIV-positive Patients after Antiretroviral Therapy Initiation at a Malaysian Referral HospitalLee Sing Chet, Siti Azrin Ab Hamid, Norsa'adah Bachok, et al.
BMC Public Health|April 9, 2026
When good knowledge falls short: identity and geography drive inappropriate antibiotic use in MalaysiaZhuo-Lin Chong, Noor Aliza Lodz, Sarbhan Singh, et al.
BMJ Open|January 12, 2026
Defining chronic ambulatory care sensitive conditions in Malaysia: a collaborative consensus studyShakirah Md Sharif, Weng Hong Fun, Suresh Kumar Chidambaram, et al.
The Lancet Regional Health. Western Pacific|February 1, 2021
Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A nationwide observational studyBenedict Lim Heng Sim, Suresh Kumar Chidambaram, Xin Ci Wong, et al.
BMC Infectious Diseases|February 15, 2019
Zika virus infection in Malaysia: an epidemiological, clinical and virological analysisYuan Liang Woon, Mei Fong Lim, Tg Rogayah Tg Abd Rashid, et al.
Nephrology (Carlton, Vic.)|April 19, 2022
COVID-19 death and kidney disease in a multiracial Asian countryBak Leong Goh, Malini Shanmuganathan, Kalaiarasu Peariasamy, et al.
BMC Infectious Diseases|August 5, 2024
Nirmatrelvir/ritonavir treatment and the risk of post-COVID condition over 180 days in MalaysiaEe Vien Low, Mohan Dass Pathmanathan, Yi Yang Ten, et al.
Pageof 2